George Clinical team members recently participated in the 12th Annual DIA China Meeting, the largest Chinese event in the life sciences industry. The conference is designed to “foster the international exchange of actionable insights to improve health globally through the advancement of lifesaving medicines and technologies in the APAC region.” Around 3,000 pharmaceutical R&D professionals attended the event to exchange ideas and practices in clinical and regulatory science
George Clinical exhibited and China country head, Zhenfei Yin, and APAC business development head, Jeremy Xie, led the China team presenting, meeting with clients, and displaying George Clinical’s global service capabilities and expanding network with other partners.
George Clinical gathered many potential collaborative opportunities during the event, and Zhenfei is expecting strong growth in the region over the next few years. DIA China is known to host professionals involved at all levels of the health care product development spectrum to discuss “transformational changes for China’s innovation and regulatory environments.”